ATLAS / Macro Radar / Reporting / RARE

Ultragenyx Pharmaceutical Inc. (RARE) reporting calendar

Ultragenyx Pharmaceutical Inc. files periodic reports with the SEC as RARE on Nasdaq. Atlas tracks 45 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
29 Jul 2026 – 14 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
6 May 2026
Reports on record
45

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open RARE market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20266 May 202636 days0001193125-26-206960
10-K31 Dec 202518 Feb 202649 days0001193125-26-057329
10-Q30 Sep 20255 Nov 202536 days0001193125-25-265126
10-Q30 Jun 20256 Aug 202537 days0000950170-25-103290
10-Q31 Mar 20257 May 202537 days0000950170-25-064726
10-K31 Dec 202419 Feb 202550 days0000950170-25-023312
10-Q30 Sep 20246 Nov 202437 days0000950170-24-121679
10-Q30 Jun 20242 Aug 202433 days0000950170-24-089488
10-Q31 Mar 20243 May 202433 days0000950170-24-052346
10-K31 Dec 202321 Feb 202452 days0000950170-24-017879
10-Q30 Sep 20233 Nov 202334 days0000950170-23-058427
10-Q30 Jun 20234 Aug 202335 days0000950170-23-038173
10-Q31 Mar 20235 May 202335 days0000950170-23-018017
10-K31 Dec 202217 Feb 202348 days0000950170-23-003096
10-Q30 Sep 20223 Nov 202234 days0000950170-22-021366
10-Q30 Jun 202229 Jul 202229 days0000950170-22-013411
10-Q31 Mar 20226 May 202236 days0000950170-22-007940
10-K31 Dec 202115 Feb 202246 days0000950170-22-001284
10-Q30 Sep 20213 Nov 202134 days0000950170-21-002687
10-Q30 Jun 20213 Aug 202134 days0001564590-21-039879
10-Q31 Mar 20215 May 202135 days0001564590-21-023501
10-K31 Dec 202012 Feb 202143 days0001564590-21-005610
10-Q30 Sep 202027 Oct 202027 days0001564590-20-047991
10-Q30 Jun 202030 Jul 202030 days0001564590-20-035082
10-Q31 Mar 20207 May 202037 days0001564590-20-022136
10-K31 Dec 201914 Feb 202045 days0001564590-20-004667
10-Q30 Sep 20196 Nov 201937 days0001564590-19-040541
10-Q30 Jun 20192 Aug 201933 days0001564590-19-028087
10-Q31 Mar 20197 May 201937 days0001564590-19-016079
10-K31 Dec 201820 Feb 201951 days0001564590-19-003324
10-Q30 Sep 20186 Nov 201837 days0001564590-18-026944
10-Q30 Jun 20183 Aug 201834 days0001564590-18-018979
10-Q31 Mar 20188 May 201838 days0001564590-18-011341
10-K31 Dec 201721 Feb 201852 days0001564590-18-002535
10-Q30 Sep 20173 Nov 201734 days0001564590-17-021336
10-Q30 Jun 201728 Jul 201728 days0001564590-17-014324
10-Q31 Mar 20175 May 201735 days0001564590-17-008895
10-K31 Dec 201617 Feb 201748 days0001564590-17-001714
10-Q30 Sep 20168 Nov 201639 days0001564590-16-028043
10-Q30 Jun 20169 Aug 201640 days0001564590-16-023403

Source: SEC EDGAR company submissions for CIK 0001515673. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.